Resultados de la búsqueda 721-730 of 1708 for tibc

  1. Oncología (médica) - Ensayos clínicos

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the ...

  3. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with ...

  4. Oncología (médica) - Ensayos clínicos

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

  5. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to evaluate how well the combination of avelumab with liposomal doxorubicin with or without binimetinib, or the ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    (estudios abiertos únicamente). Filtrar esta lista de estudios según la ubicación, el estado del estudio y más. Oligomets pancreas SBRT. Jacksonville, Fla. The ...

  7. Oncología (médica) - Ensayos clínicos

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...

  8. Oncología (médica) - Ensayos clínicos

    Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...

  9. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the safety and effectiveness of using Exablate Model 4000 Type-2.0/2.1 in adults with Glioblastoma brain tumors to ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...